ACADIA Pharmaceuticals (ACAD) Financials

$27.72

$0.14 (0.49%)

As on 09-Sep-2026 12:33EDT

Market cap

$4,828 Mln

Revenue (TTM)

$1,139 Mln

P/E Ratio

12.6

P/B Ratio

3.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1,138.64	1,071.51	957.80	726.44	517.24	484.15
Cost of Revenue	100.98	89.00	81.84	45.73	10.17	19.14
Gross Profit	1,037.66	982.51	875.96	680.71	507.07	465.00
Operating Expenses	951.30	877.70	645.16	754.09	730.67	635.44
Operating Profit (EBIT)	86.37	104.81	230.79	-73.38	-223.60	-170.44
Other Income	--	--	--	--	--	-2.33
Profit before Tax	121.37	138.90	258.08	-51.04	-213.44	-167.52
Provision for Tax	-259.12	-252.10	31.62	10.25	2.53	0.35
Profit after Tax (Net Income)	380.48	391.00	226.45	-61.29	-215.98	-167.87
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-215.98	-167.87

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,306.61	1,227.39	732.79	431.76	400.41	540.89
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	74.86	59.69	60.09	62.95	61.77	63.16
Current Liabilities	361.44	277.11	394.87	254.25	125.63	96.07
Total Liabilities	2,104.34	1,564.20	1,187.76	748.96	587.81	700.12

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	518.36	502.08	249.44	132.83	79.88	82.30
Current Assets	1,224.55	1,062.11	938.32	616.13	507.94	617.82
Total Assets	2,104.34	1,564.20	1,187.76	748.96	587.81	700.12
Total Debt*	73.85	52.19	52.00	57.21	62.00	64.43
Net Current Assets	863.11	785.00	543.45	361.87	382.31	521.76

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	109.84	157.72	16.70	-114.04	-125.66
Cash Flow from Investing Activities	--	-302.56	-30.54	32.00	73.24	-71.10
Cash from Financing Activities	--	49.88	6.85	25.13	8.20	18.16
Net Cash Inflow / Outflow	--	--	--	--	--	-178.60

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	2.22	2.28	1.36	-0.37	-1.33	-1.04
Cash EPS ($)	--	2.35	1.46	-0.33	-1.32	-1.02
Adjusted Book Value ($)	--	7.16	4.40	2.59	2.47	3.36
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.64	0.95	0.10	-0.70	-0.78
Free Cash Flow per Share ($)	--	0.61	0.94	-0.14	-0.70	-0.79

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	37.88	35.56	-12.88	-40.45	-26.19
ROE (%)	30.03	39.89	38.89	-14.73	-45.89	-28.75
ROA (%)	20.79	28.42	23.39	-9.17	-33.54	-22.64
EBIT Margin (%)	9.14	12.96	8.80	-7.03	-43.23	-35.20
Net Margin (%)	33.42	36.49	23.64	-8.44	-41.76	-34.84
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	11.75	0.12	0.32	0.40	0.07	0.10
EBIT Growth (%)	-8.52	64.81	265.14	77.17	-31.19	40.53
Net Profit Growth (%)	71.27	72.66	469.50	71.62	-28.66	40.38
EPS Growth (%)	66.63	0.68	4.70	0.72	-0.28	0.41
Book Value Growth (%)	55.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	12.57	11.71	13.48	-85.07	-11.94	-22.37
Price / Book Value	3.82	3.73	4.17	12.07	6.44	6.94
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	41.71	25.28	23.45	-106.23	-10.04	-19.74
Close Price ($)	25.30	26.71	18.35	31.31	15.92	23.34
High Price ($)	28.35	28.35	31.82	33.99	28.06	55.85
Low Price ($)	19.69	13.40	14.15	15.54	12.24	15.68
Market Cap ($ Cr)	4,828.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.04	0.07	0.13	0.15	0.12
Short term debt to equity ratio	0.01	0.01	0.01	0.02	0.02	0.02
Current Ratio	3.39	3.83	2.38	2.42	4.04	6.43
Quick Ratio	3.30	3.71	2.32	2.28	3.99	6.35
Interest Coverage	--	--	--	--	-33.83	-27.21

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.61	13.83	10.93	14.09	12.20	13.50
Asset Turnover	0.62	0.78	0.99	1.09	0.80	0.65
Receivable days	--	43.11	39.48	41.59	45.34	43.62
Inventory Days	--	116.18	128.91	169.54	260.79	167.57
Payable days	--	55.60	75.28	120.96	352.50	146.64
Cash Conversion Cycle	--	103.69	93.11	90.17	-46.36	64.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.